allergy banner

EAACI Position Papers and EAACI Task Force Reports

To add the references below to your reference management program: 1. Save the file; 2. Open your reference management program or EndNote; 3. Select File and Import

77 Articles

A practical toolbox for the effective transition of adolescents and young adults with asthma and allergies – an EAACI Position paper

Vazquez-Ortiz, M., Gore, C., Alviani, C., Angier, et al. Allergy. First published: 29 September 2022

Fungal exposome, human health and unmet needs: a 2022 update with special focus on allergy

Vitte, J., Michel, M., Malinovschi, A., et al. Allergy. 2022; 77: 3199-3216

Diagnosis and management of allergy and respiratory disorders in sport: An eaaci task force position paper

Price, O.J., Walsted, E.S., Bonini, M., et al. Allergy. First published: 09 July 2022

Role of dietary fiber in promoting immune health – An EAACI position paper

Venter, C., Meyer, R.W., Greenhawt, M., et al. Allergy. First published: 08 July 2022

Omics technologies in allergy and asthma research: an EAACI position paper

Radzikowska, U., Baerenfaller, K., Cornejo-Garcia, J.A., et al. Allergy. First published: 17 June 2022

Allergic and hypersensitivity conditions in non-specialist care: Flow diagrams to support clinical practice

Ryan, D, Flokstra – de Blok, BMJ, Clark, E, et al. Allergy. First published: 10 March 2022

Effects of non-steroidal anti-inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses. EAACI task force on eicosanoids consensus report in times of COVID-19

Sokolowska, M., Rovati, G., Diamant, Z., et al. Allergy. First published: 16 February 2022

AllergoOncology: Danger signals in allergology and oncology. A European Academy of Allergy and Clinical Immunology (EAACI) Position Paper

Bergmann, C., Poli, A., Agache, I., et al. Allergy. First published: 13 February 2022

COVID-19 vaccination in patients receiving allergen immunotherapy (AIT) or biologicals – EAACI recommendations

Jutel, M., Torres, M.J., Palomares, O., et al. Allergy. First published: 11 February 2022

Allergies and COVID-19 vaccines: An ENDA/EAACI Position paper

Barbaud, A., Garvey, L.H., Arcolaci, A., et al. Allergy. First published: 02 February 2022

Alpine Altitude Climate Treatment for severe and uncontrolled asthma: an EAACI Position Paper

Fieten, K., Drijver-Messelink, M., Cogo, A., et al. Allergy. First published: 03 February 2022

The international WAO/EAACI guideline for the management of hereditary angioedema – the 2021 revision and update

Maurer, M., Magerl, M., Betschel, S., et al. Allergy. First published: 10 January 2022

EAACI position paper on the clinical use of the bronchial allergen challenge: unmet needs and research priorities

Agache, I., Antolin-Amerigo, D., de Blay, F., et al. Allergy. First published: 02 January 2022

Proposal of 0.5 mg of protein/100 g of processed food as threshold for voluntary declaration of food allergen traces in processed food—A first step in an initiative to better inform patients and avoid fatal allergic reactions: A GA²LEN position paper

Zuberbier, T, Dörr, T, Aberer, W, et al. Allergy. First published: 06 November 2021

Hypersensitivity reactions to chemotherapy: An EAACI position paper

Pagani, M., Bavbek, S., Alvarez-Cuesta, E., et al. Allergy. First published: 29 September 2021

Perceptions of adolescents and young adults with allergy and/or asthma and their parents on EAACI guideline recommendations about transitional care: A European survey.

Khaleva, E., Knibb, R., DunnGalvin, A., et al. Allergy. First published: 26 September 2021

Current allergy educational needs in primary care. Results of the EAACI working group on primary care survey exploring the confidence to manage and the opportunity to refer patients with allergy

Cabrera, M, Ryan, D, Angier, E, et al. Allergy. First published: 09 September 2021

One Health: EAACI position paper on coronaviruses at the human-animal interface, with a specific focus on comparative and zoonotic aspects of SARS-Cov-2

Korath, ADJ, Janda, J, Untersmayr, E, et al. Allergy.First published: 28 June 2021

Hypersensitivity reactions to biologicals: An EAACI position paper

Bavbek, S., Pagani, M., Alvarez-Cuesta, E., et al. Allergy.First published: 22 June 2021

Technical standards in allergen exposure chambers worldwide – an EAACI task force report

Pfaar, O., Bergmann, K., Bonini, S., et al. Allergy. First published: 24 May 2021

Adherence to the strengthening the reporting of observational studies in epidemiology (STROBE) checklist in articles published in EAACI journals: A bibliographic study

Wiehn, E., Ricci, C., Alvarez-Perea, A., et al. Allergy. First published: 22 May 2021

Dangerous liaisons: Bacteria, antimicrobial therapies, and allergic diseases

Tramper-Stranders, G, Ambrożej, D, Arcolaci, A, et al. Allergy. 2021; 76: 3276– 3291

Health effects of exposure to chlorination by-products in swimming pools

Couto, M, Bernard, A, Delgado, L, et al. Allergy. 2021; 76: 3257– 3275

Management of anaphylaxis due to COVID-19 vaccines in the elderly

Bousquet, J., Agache, I., Blain, H., et al. Allergy. 2021; 76: 2952-2964

Allergen immunotherapy: the growing role of observational and randomisedtrial “Real-World Evidence”

Paoletti, G., DiBona, D., Chu, D.K., et al. Allergy. 2021; 76: 2663-2672

Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA2LEN consensus

Hagemann, J., Onorato, G.L., Jutel, M., et al. Allergy. 2021; 76: 2354-2366

EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccines

Sokolowska, M., Eiwegger, T., Ollert, M., et al. Allergy. 2021; 76: 1629-1639

ARIA-EAACI statement on severe allergic reactions to COVID-19 vaccines – an EAACI-ARIA position paper

Klimek, L., Jutel, M., Akdis, C.A., Allergy. 2021; 76: 1624-1628

Practice parameters for diagnosing and managing iodinated contrast media hypersensitivity

Torres, MJ, Trautmann, A, Böhm, I, et al. Allergy. 2021; 76: 1325– 1339

Noninvasive and minimally invasive techniques for the diagnosis and management of allergic diseases

Baumann, R, Untersmayr, E, Zissler, UM, et al.Allergy. 2021; 76: 1010– 1023

ARIA-EAACI statement on asthma and COVID-19 (June 2, 2020)

Bousquet, J., Jutel, M., Akdis, C.A., et al. Allergy. 2021; 76: 689-697

Management of patients with chronic rhinosinusitis during the COVID-19 pandemic—An EAACI position paper

Klimek, L, Jutel, M, Bousquet, J, et al. Allergy. 2021; 76: 677– 688

COVID-19 pandemic: Practical considerations on the organization of an allergy clinic—An EAACI/ARIA position paper

Pfaar, O, Klimek, L, Jutel, M, et al. Allergy. 2021; 76: 648– 676

Placebo effects in allergen immunotherapy – an EAACI task force position paper

Pfaar, O, Agache, I, Bergmann, KC, et al. Allergy. 2021; 76: 629– 647

Current perspective on eicosanoids in asthma and allergic diseases: EAACI task force consensus report, part I

Sokolowska, M, Rovati, GE, Diamant, Z, et al. Allergy. 2021; 76: 114– 130

Immune modulation via T regulatory cell enhancement: Disease-modifying therapies for autoimmunity and their potential for chronic allergic and inflammatory diseases—An EAACI position paper of the task force on immunopharmacology (TIPCO)

Roth-Walter, F, Adcock, IM, Benito-Villalvilla, C, et al. Allergy. 2021; 76: 90– 113

Biologicals in atopic disease in pregnancy: An EAACI position paper

Pfaller, B, José Yepes-Nuñez, J, Agache, I, et al. Allergy. 2021; 76: 71– 89

The development of birch pollen seasons over 30 years in Munich, Germany—An EAACI task force report

Bergmann, K.-C., Buters, J., Karatzas, K., et al. Allergy. 2020; 75: 3024-3026

Diagnosis and management of the drug hypersensitivity reactions in coronavirus disease 19: An EAACI position paper

Gelincik, A, Brockow, K, Çelik, GE, et al. Allergy. 2020; 75: 2775– 2793

Considerations on biologicals for patients with allergic disease in times of the COVID-19 pandemic: An EAACI statement

Vultaggio, A, Agache, I, Akdis, CA, et al. Allergy. 2020; 75: 2764– 2774

Gender and occupational allergy: Report from the task force of the EAACI Environmental and Occupational Allergy Interest Group

Moscato, G, Apfelbacher, C, Brockow, K, et al. Allergy. 2020; 75: 2753– 2763

Immunology of COVID-19: Mechanisms, clinical outcome, diagnostics, and perspectives—A report of the European Academy of Allergy and Clinical Immunology (EAACI)

Sokolowska, M, Lukasik, ZM, Agache, I, et al. Allergy. 2020; 75: 2445– 2476

Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement

Bousquet, J., Akdis, C.A., Jutel, M. Allergy, 75: 2440-2444

In-vivo diagnostic test allergens in Europe: A call to action and proposal for recovery plan—An EAACI position paper

Klimek, L, Hoffmann, HJ, Kalpaklioglu, AF, et al. Allergy. 2020; 75: 2161– 2169

EAACI Research and Outreach Committee: Improving standards and facilitating global collaboration through a Research Excellence Network

Shamji, M.H., Akdis, C.A., Barber, D., et al. Allergy. 2020; 75: 1899-1901

The effectiveness of interventions to improve self-management for adolescents and young adults with allergic conditions: A systematic review

Knibb, RC, Alviani, C, Garriga-Baraut, T, et al. Allergy. 2020; 75: 1881– 1898

Understanding the challenges faced by adolescents and young adults with allergic conditions: A systematic review

Vazquez-Ortiz, M, Angier, E, Blumchen, K, et al. Allergy. 2020; 75: 1850– 1880

Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement

Klimek, L, Jutel, M, Akdis, C, et al. Allergy. 2020; 75: 1546– 1554

Towards a more precise diagnosis of hypersensitivity to beta-lactams - an EAACI position paper

Romano, A, Atanaskovic-Markovic, M, Barbaud, A, et al. Allergy. 2020; 75: 1300– 1315

Pollen season is reflected on symptom load for grass and birch pollen-induced allergic rhinitis in different geographic areas—An EAACI Task Force Report

Pfaar, O, Karatzas, K, Bastl, K, et al. Allergy. 2020; 75: 1099– 1106

Genetic variants associated with T cell-mediated cutaneous adverse drug reactions: A PRISMA-compliant systematic review-An EAACI position paper

Oussalah, A, Yip, V, Mayorga, C, et al. Allergy. 2020; 75: 1069– 1098

State-of-the-art in marketed adjuvants and formulations in Allergen Immunotherapy: A position paper of the European Academy of Allergy and Clinical Immunology (EAACI)

Jensen-Jarolim, E, Bachmann, MF, Bonini, S, et al. Allergy. 2020; 75: 746– 760

EAACI position paper on diet diversity in pregnancy, infancy and childhood: Novel concepts and implications for studies in allergy and asthma

Venter, C, Greenhawt, M, Meyer, RW, et al. Allergy. 2020; 75: 497– 523

The role of mobile health technologies in allergy care: An EAACI position paper

Matricardi, P, Dramburg, S, Alvarez-Perea, A, et al. Allergy. 2020; 75: 259– 272

Diagnosis and management of Non-IgE gastrointestinal allergies in breastfed infants-An EAACI Position Paper

Meyer, R, Chebar Lozinsky, A, Fleischer, DM, et al. Allergy. 2020; 75: 14– 32

Prioritizing research challenges and funding for allergy and asthma and the need for translational research—The European Strategic Forum on Allergic Diseases

Agache, I, Annesi-Maesano, I, Bonertz, A, et al. Allergy. 2019; 74: 2064– 2076

An EAACI position paper on the investigation of perioperative immediate hypersensitivity reactions

Garvey, LH, Ebo, DG, Mertes, P-M, et al. Allergy. 2019; 74: 1872– 1884

Food processing and occupational respiratory allergy- An EAACI position paper

Jeebhay, MF, Moscato, G, Bang, BE, et al. Allergy. 2019; 74: 1852– 1871

Toward clinically applicable biomarkers for asthma: An EAACI position paper

Diamant, Z, Vijverberg, S, Alving, K, et al. 2019; 74: 1835- 1851

Management of ocular allergy.

Leonardi, A, Silva, D, Perez Formigo, D, et al. Allergy. 2019; 74: 1611– 1630

EAACI position paper: Influence of dietary fatty acids on asthma, food allergy, and atopic dermatitis

Venter, C, Meyer, RW, Nwaru, BI, et al. Allergy. 2019; 74: 1429– 1444

A EAACI drug allergy interest group survey on how European allergy specialists deal with beta-lactam allergy

Torres, MJ, Celik, GE, Whitaker, P, et al. Torres, MJ, Celik, GE, Whitaker, P, et al. Allergy. 2019; 74: 1052– 1062

AllergoOncology: Microbiota in allergy and cancer—A European Academy for Allergy and Clinical Immunology position paper

Untersmayr, E, Bax, HJ, Bergmann, C, et al. Allergy. 2019; 74: 1037– 1051

EAACI position paper: Comparing insect hypersensitivity induced by bite, sting, inhalation or ingestion in human beings and animals

Pali-Schöll, I, Blank, S, Verhoeckx, K, et al. Allergy. 2019; 74: 874– 887

Emerging concepts and challenges in implementing the exposome paradigm in allergic diseases and asthma: a Practall document

Agache, I, Miller, R, Gern, JE, et al. Allergy. 2019; 74: 449– 463

Comparing biologicals and small molecule drug therapies for chronic respiratory diseases: An EAACI Taskforce on Immunopharmacology position paper

Roth-Walter, F, Adcock, IM, Benito-Villalvilla, C, et al. Allergy. 2019; 74: 74: 432– 448

Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD)—a EAACI position paper

Kowalski, ML, Agache, I, Bavbek, S, et al. Allergy. 2019; 74: 28– 39

EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivity

Brockow, K, Ardern-Jones, MR, Mockenhaupt, M, et al. Allergy. 2019; 74: 28– 39

Allergen immunotherapy in people, dogs, cats and horses – differences, similarities and research needs

Mueller, RS, Jensen-Jarolim, E, Roth-Walter, F, et al. Allergy. 2018; 73: 1989– 1999

The urgent need for a harmonized severity scoring system for acute allergic reactions

Muraro, A, Fernandez-Rivas, M, Beyer, K, et al. Allergy. 2018; 73: 1792– 1800

EAACI Position paper on the standardization of nasal allergen challenges

Augé, J, Vent, J, Agache, I, et al. Allergy. 2018; 73: 1597– 1608

Influenza burden, prevention, and treatment in asthma-A scoping review by the EAACI Influenza in asthma task force

Schwarze, J, Openshaw, P, Jha, A, et al. Allergy. 2018; 73: 1151– 1181

Emerging roles of innate lymphoid cells in inflammatory diseases: Clinical implications

Kortekaas Krohn, I, Shikhagaie, MM, Golebski, K, et al. Allergy. 2018; 73: 837– 850

Challenges in the implementation of the EAACI AIT guidelines: A situational analysis of current provision of allergen immunotherapy

Ryan, D, Gerth van Wijk, R, Angier, E, et al. Allergy. 2018; 73: 827– 836

The roadmap for allergology in Europe: The subspecialty of allergology as “stop-over” on the way to a full specialty. An EAACI position statement

Gerth van Wijk, R, Eguiluz-Gracia, I, Gayraud, J, et al. 2018; 73: 540– 548

AllergoOncology: Opposite outcomes of immune tolerance in allergy and cancer

Jensen-Jarolim, E, Bax, HJ, Bianchini, R, et al. Allergy. 2018; 73: 328– 340

Current practice of allergy diagnosis and the potential impact of regulation in Europe

Cardona, V, Demoly, P, Dreborg, S, et al. Allergy. 2018; 73: 323- 327